Atlas FDA

Predicate Research Report · generated 2026-08-22 · Print / save as PDF · Save to account

Bioland Technology, Ltd. — Predicate Candidate Screening

8 FDA 510(k) clearances under this manufacturer; the 50 most recent screened below.

197 daysmedian FDA review time
693 days90th percentile
8clearances measured
K-numberDeviceApplicantDecidedReview daysRecalls (K-match)
K202739Bioland G-425-2V Blood Glucose Monitoring System, Bioland G-Bioland Technology, Ltd.2022-08-126930
K213011Infrared Thermometer (model: E201)Bioland Technology, Ltd.2022-04-051970
K201879Digital Thermometer Model T103, T104Bioland Technology, Ltd.2021-03-312670
K202934Blood Pressure MonitorBioland Technology, Ltd.2021-01-261190
K201161Infrared Thermometer Model E127Bioland Technology, Ltd.2020-10-021550
K201467Blood Pressure Monitor-Model 2005, 2006-2, 2006-2BBioland Technology, Ltd.2020-09-211110
K191657Bioland Blood Glucose Monitoring SystemBioland Technology, Ltd.2020-03-202730
K083681BIOLAND BLOOD PRESSURE MONITORBioland Technology, Ltd.2009-01-16350

Methodology

Recall counts reflect FDA recall records explicitly referencing each K-number; FDA links recalls to K-numbers inconsistently, so 0 means "none found in FDA records," not "never recalled." Data: FDA openFDA, refreshed weekly. Verify decisions of consequence against the primary source. Full candidate set and CSV export: atlasbyauro.com.

Prepared with Atlas

Predicate research, review-time statistics and recall monitoring for 510(k) teams — atlasbyauro.com/fda